An effective research and standardized development process is absolutely central to IMSaT’s success and we will continue to invest heavily in this aspect.
Key features of IMSaT’s process:
IMSaT collaborates with health service providers and corporate partners at all stages, from early stage scientific research to the development of specific biomedical devices. IMSaT typically completes the transfer of development activities to its corporate partner(s) activities during the Pre-Clinical Trials Phase of the process.
Certification of IMSaT’s development processes (ISO, GLP, etc.) will facilitate the efficient, economic transfer of new device technologies to our corporate partners.
